Kalaris Therapeutics KLRS
NASDAQ KLRS
$2.89 -0.01 (-0.34%)
At close: Sep 30, 2026 · 4:00 PM EDT

Kalaris Therapeutics (KLRS) Capital Expenditures (2019 - 2025)

Updated

Kalaris Therapeutics' Capital Expenditures was $17,000 in Q4 2025.

Analysis

Kalaris Therapeutics (KLRS) Capital Expenditures (2019 - 2025) Analysis & Trends

For FY2025, Capital Expenditures at Kalaris Therapeutics came in at $200,000.

  • Capital Expenditures shows a five-year compound annual growth rate of -3.2% (FY2020 to FY2025).
  • In earlier years, Capital Expenditures was $26,000 in FY2021 (-88.9%).
  • The Q4 2025 figure marks the highest quarterly Capital Expenditures since Q3 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capex (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.32 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 322.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 893.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -321.00 Mn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -763.00 Mn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 513.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 140.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 533.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 112.20 Mn
10 Kalaris Therapeutics 68.80 Mn 68.80 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 17,000.00
Dec 31, 2021 -370,000.00
Sep 30, 2021 33,000.00
Jun 30, 2021 288,000.00
Mar 31, 2021 75,000.00
Dec 31, 2019 121,000.00
Sep 30, 2019 -7,000.00
API Access

Kalaris Therapeutics Capital Expenditures API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=capital-expenditures&ticker=KLRS&period=max&api_key=YOUR_API_KEY